Afficher la notice abrégée

dc.creatorMarmaras N., Xirogianni A., Papandreou A., Petinaki E., Papaevangelou V., Tsolia M., Tzanakaki G.en
dc.date.accessioned2023-01-31T08:57:40Z
dc.date.available2023-01-31T08:57:40Z
dc.date.issued2021
dc.identifier10.3390/diagnostics11122353
dc.identifier.issn20754418
dc.identifier.urihttp://hdl.handle.net/11615/76385
dc.description.abstractAs almost 60–70% of Invasive Pneumococcal Disease (IPD) is identified by nonculture methods in Greece, serotyping is of high importance for the better monitoring of pneumococcal serotypes due to the availability of conjugate vaccines. The aim of the study was the modification and direct application of the Capsular Sequence Typing (CST) assay in clinical samples in order to serotype Streptococcus pneumoniae culture-negative, Polymerase Chain Reaction (PCR_-positive samples, followed by CST group specific single-tube PCR assays. A two-step PCR modified assay was applied on a total of 306 samples (such as CSF, blood, pleural and middle ear fluids, isolates) obtained from 283 patients with IPD. The overall performance permits a rapid, accurate and cost-effective method for nonculture pneumococcal serotyping. As the management of IPD is closely related to the continuous monitoring of pneumococcal serotypes, the proposed approach proved to be a valuable tool for the typing and epidemiological monitoring of S. pneumoniae, for the evaluation of the overall impact of vaccination programs in the era of pneumococcal conjugate vaccines, in order to initiate the appropriate vaccination strategy. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.en
dc.language.isoenen
dc.sourceDiagnosticsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85121578390&doi=10.3390%2fdiagnostics11122353&partnerID=40&md5=4c51b731145dd6495fb3ce23a246a67a
dc.subjectPneumococcus vaccineen
dc.subjectarthritisen
dc.subjectArticleen
dc.subjectblooden
dc.subjectcapsular sequence typing assayen
dc.subjectcerebrospinal fluiden
dc.subjectclinical featureen
dc.subjectcost effectiveness analysisen
dc.subjectepidemiological monitoringen
dc.subjecthumanen
dc.subjectmajor clinical studyen
dc.subjectmeningitisen
dc.subjectmiddle earen
dc.subjectotitis mediaen
dc.subjectpleura fluiden
dc.subjectpneumoniaen
dc.subjectpolymerase chain reactionen
dc.subjectsepticemiaen
dc.subjectserotypeen
dc.subjectserotypingen
dc.subjectStreptococcus pneumoniaeen
dc.subjectvaccinationen
dc.subjectMDPIen
dc.titlePneumococcal serotype identification by capsular sequence typing (Cst): A modified novel approach for serotyping directly in clinical samplesen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée